Shilpa Gupta Profile Banner
Shilpa Gupta Profile
Shilpa Gupta

@shilpaonc

7,438
Followers
1,951
Following
767
Media
16,126
Statuses

GU oncologist, clinical trialist, Director GU Oncology @CleclinicMD Tweets my own, RT/Likes not active endorsement.

Cleveland, OH
Joined January 2016
Don't wanna be here? Send us removal request.
@shilpaonc
Shilpa Gupta
3 months
🎉Excited to announce my promotion to Professor @CleClinicMD @CWRUSOM Grateful to my family, friends & colleagues for believing in me & supporting me. Special thx to my incredible boys, Arash & Arav who have been my rock through it all! @jamecancerdoc @MoffittNews @umnmedschool
Tweet media one
82
25
327
@shilpaonc
Shilpa Gupta
9 months
An indescribable, overwhelming feeling to see our 1st pt on EV Pembro on EV-302 w/ ongoing CR since the 1st scan ~ 3 yrs ago! He has traveled to over 20 countries across 5 continents while on tx. Grateful to our wonderful team @CleClinicMD for making this study a huge success!
Tweet media one
10
25
203
@shilpaonc
Shilpa Gupta
5 years
39
12
180
@shilpaonc
Shilpa Gupta
3 years
Volunteering to help cover admissions for myeloma service due to staff diversion for Covid surge. @CleClinicMD #GetVaccinatedAndBoosted #VaccinesWork #WeCanDoThis #StaySafe
Tweet media one
20
3
177
@shilpaonc
Shilpa Gupta
2 years
Eagerly waiting for THE @DGlaucomflecken to give grand rounds on “Humor in Medicine” @CleClinicMD on April 29 A not to be missed event! @jamecancerdoc @ChrisWeeMD @CCF_IMCHIEFS
Tweet media one
9
12
164
@shilpaonc
Shilpa Gupta
5 years
Excited to start a new chapter in my journey @ClevelandClinic today after a great experience @UMNCancer Looking forward to new beginnings and adventures!
36
5
158
@shilpaonc
Shilpa Gupta
2 years
Thanks @DGlaucomflecken for such a powerful,touching & humorous grandrounds @CleClinicMD & providing us an Rx for humor today while sharing your own personal experience as a testicular ca and cardiac arrest survivor @jamecancerdoc @MosheOrnsteinMD @ChrisWeeMD @TimGilliganMD
Tweet media one
Tweet media two
Tweet media three
6
8
151
@shilpaonc
Shilpa Gupta
1 year
On my way to @myESMO 🇪🇸to learn the latest advances in #GUOnc with multiple practice changing trials & meet friends & colleagues! Will need to absorb all the data to win the @Uromigos #UromigosLive competition 🏆 #TeamCleveland @tompowles1 @brian_rini
Tweet media one
4
6
134
@shilpaonc
Shilpa Gupta
5 months
After wrapping up a busy day in clinic, en route to #ASCO24 @ASCO ! Looking forward to learning the latest advances in oncology, sharing our work & meeting friends & colleagues! @CleClinicMD @MosheOrnsteinMD @AmandaNizamMD
Tweet media one
2
6
124
@shilpaonc
Shilpa Gupta
3 years
@jamecancerdoc
Jame Abraham, MD, FACP
3 years
Please congratulate ⁦ @shilpaonc ⁩ being appointed as the Director of GU Medical Oncology and co- leader of GU oncology program at ⁦ @ClevelandClinic ⁩ ⁦ @CleClinicMD ⁩ ⁦ @CleClinicNews
Tweet media one
Tweet media two
69
33
324
22
5
124
@shilpaonc
Shilpa Gupta
2 years
Excited to be on my way to #ASCO22 @ASCO to learn the latest science and meet friends and colleagues @ASCO @ConquerCancerFd @CleClinicMD
Tweet media one
5
3
121
@shilpaonc
Shilpa Gupta
1 year
On my way to #ASCO23 Looking forward to meeting friends and learning the latest advances in oncology! @CleClinicMD
Tweet media one
3
0
121
@shilpaonc
Shilpa Gupta
3 years
Beautiful sunrise by the Ganges in Varanasi 🇮🇳
Tweet media one
Tweet media two
Tweet media three
7
1
101
@shilpaonc
Shilpa Gupta
2 years
A beautiful morning in Gulmarg, Kashmir 🇮🇳 aka paradise on earth!
Tweet media one
Tweet media two
5
2
98
@shilpaonc
Shilpa Gupta
2 years
Honored to have @DrChoueiri kick off our in-person grand rounds @CleClinicMD @caseccc @UHhospitals @CleClinicUro What an extraordinary talk on the past, present & future in RCC & his seminal contributions to the field. @MosheOrnsteinMD @ChrisWeeMD @AmandaNizamMD @TimGilliganMD
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
16
99
@shilpaonc
Shilpa Gupta
11 months
Wishing Happy Diwali 🪔 to all those who celebrate! Victory of #GoodOverEvil #LightOverDarkness 🪔🪔 @ShuchiGulati @sandysrimd @Aiims1742
Tweet media one
10
6
99
@shilpaonc
Shilpa Gupta
2 years
@ASCO abstracts submitted few hours ahead of the deadline tonight. Now looking forward to attending #GU23 to learn about the latest advances in GU cancers and interact with friends and colleagues! @CleClinicMD
Tweet media one
5
3
93
@shilpaonc
Shilpa Gupta
2 years
Always love arriving home at the incredible @DelhiAirport 🇮🇳
Tweet media one
7
0
93
@shilpaonc
Shilpa Gupta
1 year
@neerajaiims
Neeraj Agarwal, MD, FASCO
1 year
Ab #4505 #ASCO23 @ASCO : EV-103 dose escalation/cohort A ≈ 4 yrs f/u➡️after a median of 9 cycles: ORR: 73.3%, DCR: 84.4%, CR: 15.6%, median DOR: 22.1 months, median PFS 12.7 months in 1L cis-ineligible pts with locally advanced/mUC #bladdercancer 👉
Tweet media one
Tweet media two
Tweet media three
0
32
62
7
15
91
@shilpaonc
Shilpa Gupta
2 years
@jackiebrown_MD @costplusdrugs @mcuban @costplusdrugs has been a life saver for patients with #ProstateCancer Glad we are finally using this low dose, driven by @JanssenUS stopping PAP
60
9
80
@shilpaonc
Shilpa Gupta
3 years
Thrilled to announce activation of our ph3 RCT MAINCAV of maintenance avelumab vs avelumab+cabozantinib in mUC @ALLIANCE_org @NCICancerTrials @morr316 @DrRosenbergMSK @CleClinicMD Please consider opening at your sites! … (1/1)
Tweet media one
Tweet media two
17
17
90
@shilpaonc
Shilpa Gupta
5 years
Amazing sand art by @sudarsansand 🇮🇳 in support of Medical personnel risking their lives to save people and urging people to #StayHome #SocialDistanacing #COVID19 @ravimehro @satya_yadav @anandoncologist @neerajaiims @UroDocAsh @montypal @AnantBhan
@sudarsansand
Sudarsan Pattnaik
5 years
Let’s salute all the medical teams around the world, who stand on the front line of #COVID19 fighting .My sand art at Puri beach, India which shows the medical teams appeal citizen with the message "I stayed at work for you", "You stay at home for Us". #SatyAtHomeSatySafe
Tweet media one
8
395
1K
3
27
87
@shilpaonc
Shilpa Gupta
2 years
Excited to receive my swag for my 1st in-person @bikeVeloSano ride @CleClinicMD Every dollar goes towards cancer research.
Tweet media one
Tweet media two
0
10
89
@shilpaonc
Shilpa Gupta
3 years
So excited about the opportunity to co-lead @hoosiercancer #GU working group with my partner in crime @DrRanaMcKay @CleClinicMD @UCSDnews Grateful to prior co-chairs @MattGalsky @sonpavde Noah Hahn on developing such a rich and high impact trial portfolio!
@hoosiercancer
Hoosier Cancer
3 years
We are happy to announce the appointment of @shilpaonc of @ClevelandClinic and @DrRanaMcKay of @UCSDHealth as co-chairs of HCRN's #Genitourinary working group!
Tweet media one
1
3
41
11
9
87
@shilpaonc
Shilpa Gupta
8 months
We report for the 1st time therole of tumor fraction in ctDNA in pts w/ mUC in RW @FoundationATCG 👉 ass. w/ clinico-path features & rwPFS 👉prognostic biomarker 👉may help personalize tx 👉prospective trials needed @myESMO @ElsevierNews @CleClinicMD
Tweet media one
Tweet media two
Tweet media three
8
21
82
@shilpaonc
Shilpa Gupta
2 years
Tranquil beauty of Pahalgaon, Kashmir🇮🇳
Tweet media one
Tweet media two
Tweet media three
6
1
82
@shilpaonc
Shilpa Gupta
10 months
Congratulations @tompowles1 on being featured in @Nature Nature’s10 2023 as the “Cancer Explorer” for your tremendous contribution to advancing #bladderca Tx #EV302 ! @Uromigos The cancer physician who helped to deliver a life-extending treatment
4
17
79
@shilpaonc
Shilpa Gupta
6 months
Happy to share our review on adj Tx MIUC (pre-EAU) lot of progress w/ IMvigor010, AMBASSADOR, CM274, PROOF302, POUT trials. @ChHobeika @fuatbcr @CleClinicMD Adjuvant Therapy for Muscle-Invasive Urothelial Cancer: Current Eviden...
Tweet media one
4
21
81
@shilpaonc
Shilpa Gupta
9 months
Grateful to be selected as the Reviewer of the Month by @EUplatinum E-mails like this appreciating one's work as a reviewer make the effort all the more worthwhile. Thanks @Albert0Briganti for the recognition! @UroDocAsh @spsutkaMD @neerajaiims @montypal
Tweet media one
11
11
81
@shilpaonc
Shilpa Gupta
4 years
On service on Thanksgiving and feeling even more grateful for every little and big thing we take granted everyday. Happy Thanksgiving! #grateful
Tweet media one
4
2
79
@shilpaonc
Shilpa Gupta
4 months
Tweet media one
Tweet media two
Tweet media three
Tweet media four
5
11
79
@shilpaonc
Shilpa Gupta
10 months
Our work on plat-ineligibility in mUC and survival outcomes out in @JNCI_Now (1/3) 👉1st to provide quantitative benchmarks 👉only 11% of >4K pts plat-ineligible 👉poor median OS ~5 mos @CleClinicMD @ChrisWeeMD @GUONCGarciaJA @caseccc
Tweet media one
Tweet media two
7
24
79
@shilpaonc
Shilpa Gupta
5 months
Tweet media one
Tweet media two
Tweet media three
11
17
79
@shilpaonc
Shilpa Gupta
2 years
Very honored, excited (and nervous) to discuss oral abstracts (LBA4505 #Dr . Robert Jones, @tompowles1 ) and abstract #4504 by @montypal on cabozantinib and cabozantinib atezo in mUC @ASCO #ASCO2022 @CleClinicMD @neerajaiims 👇
Tweet media one
Tweet media two
@urotoday
UroToday.com
2 years
Is there a role for VEGF-TKIs in #BladderCancer ? Looking forward to #ASCO22 presentation by @shilpaonc @CleClinicMD this Friday, June 3rd! @ASCO
Tweet media one
0
1
6
8
14
78
@shilpaonc
Shilpa Gupta
2 years
Tweet media one
Tweet media two
7
10
74
@shilpaonc
Shilpa Gupta
7 months
Love the amazing feeling of coming home @DelhiAirportGMR 🇮🇳
Tweet media one
4
2
71
@shilpaonc
Shilpa Gupta
11 months
Delighted to share our Platinum Priority editorial @EuropeanUrology Oncology on #LEAP -011 trial w/ @AndreaNecchi Congrats @PGrivasMDPhD @y_loriot on leading this informative trial of pembro+lenvatinib vs pembro in 1L mUC
Tweet media one
4
18
71
@shilpaonc
Shilpa Gupta
2 years
After the press release of TALAPRO-2, exciting to see TIP poster of #TALAPRO -3, ph 3 RCT of enza+talazoparib vs placebo +enza in met hormone-sensitive #ProstateCancer pts with DDR+ tumors presented by @neerajaiims #PCFRetreat22
Tweet media one
0
23
70
@shilpaonc
Shilpa Gupta
4 years
Honored to have our BLASST-1 trial neoadjuvant Nivo+GC in #BladderCa featured in Cancer Advances @CleClinicMD Thanks to everyone who made it a success @sonpavde @cjweight @neerajaiims @ewanagibb @Davicioni @maughanonc Sumati Gupta Badri Konety @RushUniversity and many others!
Tweet media one
Tweet media two
3
9
69
@shilpaonc
Shilpa Gupta
7 months
Grateful & honored to be a part of EV302 setting EVpembro as the new SOC. Thx to all pts who enrolled on it & Congrats to all investigators worldwide & our team @CleClinicMD for making this a huge success. @tompowles1 @ChrisWeeMD @MosheOrnsteinMD @AmandaNizamMD @TimGilliganMD
@tompowles1
Tom Powles
7 months
Enfortumab + Pembro outperforms platinum chemotherapy in advanced UC with a doubling of PFS and a halving of the risk of death @nejm . G3/4 AEs of 56% for EVP vs 70% for chemo & CR=29%. Editorial by @gniegisch ‘EVP is the new standard against which future trials must be compared’
Tweet media one
Tweet media two
Tweet media three
Tweet media four
17
131
354
6
7
70
@shilpaonc
Shilpa Gupta
2 years
Got my #FluShot #COVIDBooster shots today because they only work if actually taken (just like screening colonoscopies)! @CleClinicMD #VaccinesSaveLives
Tweet media one
1
0
70
@shilpaonc
Shilpa Gupta
3 months
Thanks @jamecancerdoc for all your support always! Grateful for your kindness and leadership!
@jamecancerdoc
Jame Abraham, MD, FACP
3 months
Please join me in congratulating ⁦ @shilpaonc ⁩ who is promoted to Professor of Medicine ⁦ @CleClinicLCM ⁩ ⁦ @cwru ⁩ ⁦ @CleClinicMD ⁩ ⁦ @ClevelandClinic ⁩ !!
Tweet media one
28
10
161
13
2
69
@shilpaonc
Shilpa Gupta
2 years
Wishing all my friends and those who celebrate a very Happy Dusshera, symbolic for victory of good over evil!
Tweet media one
4
6
67
@shilpaonc
Shilpa Gupta
29 days
Honored to co-chair Proffered Paper #Bladderca session #ESMO24 w/ the amazing @mdesantis234 All 🌟 line of up speakers & presentations! @AndreaNecchi @BogdanaSchmidt Thx @PGrivasMDPhD for your superb leadership of GU Non-Pca track @myESMO @montypal @DrChoueiri @neerajaiims
Tweet media one
Tweet media two
Tweet media three
Tweet media four
4
11
67
@shilpaonc
Shilpa Gupta
9 months
#GU24 @ASCO Looking forward to co-chairing an exciting session around key Qs in IO sequencing, pairing & re-challenging w/ @DrJohnSfakianos An all 🌟line-up of speakers!! @WilliamKimMD @montypal #Peter O’Donnell #Dan Geynisman 👉Fri, Jan 26 2.30 PM PST
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
19
67
@shilpaonc
Shilpa Gupta
6 years
Have 4 patients admitted on service with serious multi-system immune-related AEs. Need to create more awareness among care providers at 1st point of contact, emergency room providers @PGrivasMDPhD @montypal @neerajaiims @apolo_andrea @ERPlimackMD @SuzanneColeMD
4
8
65
@shilpaonc
Shilpa Gupta
2 years
Congrats @neerajaiims on >10K followers @Twitter Thanks for all your hard work & passion that went into disseminating info from cutting edge science #ASCO22 @ASCO @ASCOPost @OncBrothers @OncoAlert @apolo_andrea @montypal @crisbergerot @PauloBergerot @PGrivasMDPhD @Huntsman_GU
6
9
66
@shilpaonc
Shilpa Gupta
1 year
Check out our poster #ASCO23 on effect of antibiotics on efficacy of IO in our real world cohort of > 300 mUC pts @CleClinicMD Abx use prior to IO significantly worsens OS. Congrats @UbenthiraP on presenting this work @CleClinicMD @MosheOrnsteinMD @ChrisWeeMD @TimGilliganMD
Tweet media one
Tweet media two
3
15
63
@shilpaonc
Shilpa Gupta
9 months
@ASCO #GU24 @ChHobeika @CleClinicMD presents our work on type of antibiotics and detrimental effect on outcomes with ICI in mUC. Important practice influencing data.
Tweet media one
Tweet media two
2
19
61
@shilpaonc
Shilpa Gupta
2 years
@gavinthomas2015 I see a big dog
11
0
64
@shilpaonc
Shilpa Gupta
3 years
Immunotherapy As Curative Therapy in Advanced Kidney and Bladder Cancer: Fantasy or Reality? A brilliant thought- provoking presentation by @tompowles1 #ASCO21 @ASCO
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
12
63
@shilpaonc
Shilpa Gupta
6 years
Thanks #clincancerresearch @AACR for publishing our manuscript on seviteronel, novel dual AR antagonist/CYP17 inhibitor in #ProstateCancer . Fortunate to have led this collaborative work @MoffittNews @UMN_Cancer with Dr. Neal Shore and others
5
14
63
@shilpaonc
Shilpa Gupta
6 months
Amazing to see our 1st pt on EV-302 (EV+P arm) still in CR after 3 yrs featured in our @caseccc Annual Report EV+P sets the bar high for efficacy & QoL. Thx to our pts & team @CleClinicMD for making this study a success. @tompowles1 @DrRosenbergMSK
Tweet media one
Tweet media two
Tweet media three
4
8
63
@shilpaonc
Shilpa Gupta
2 years
Bright & picturesque saffron fields in Kashmir valley 🇮🇳
Tweet media one
Tweet media two
5
0
64
@shilpaonc
Shilpa Gupta
2 months
What an amazing #BCANTT24 it was! Thx @eugene_pietzak @bcan_chisolm @BCAN_Research , SC members, co-chairs, speakers, pt advocates & attendees for a fantastic meeting. It was all about patients from beginning to end! Looking forward to working w/ @MaxKates for planning #BCANTT25
Tweet media one
Tweet media two
Tweet media three
Tweet media four
@BladderCancerUS
Bladder Cancer Advocacy Network
2 months
That's a wrap for BCAN's 2024 Think Tank, #BCANTT24 . Thank you everyone for 2.5 amazing days of learning, collaboration, catching up with old friends and making new ones. We can't wait to see you next year in Washington, DC for #BCANTT25 !
Tweet media one
0
9
32
4
11
63
@shilpaonc
Shilpa Gupta
2 years
Tweet media one
5
5
63
@shilpaonc
Shilpa Gupta
2 years
Tweet media one
3
3
62
@shilpaonc
Shilpa Gupta
3 years
Looking forward to #ASCO21 and excited to be part of the @SWOG S1216 phase 3 trial being presented by @neerajaiims ADT+TAK-700 vs ADT-bicalutamide in #mHSPC @jamecancerdoc #cleclincancer @Huntsman_GU @PCF_Science @CleClinicMD
2
20
62
@shilpaonc
Shilpa Gupta
6 months
Glad to be in #Cleveland for #SolarEclipse2024 Hoping to see the #totality
Tweet media one
3
2
62
@shilpaonc
Shilpa Gupta
1 year
#ASCO23 My best workout ever!
Tweet media one
1
6
61
@shilpaonc
Shilpa Gupta
1 year
The master @DrChoueiri back in Cleveland giving the keynote presentation on “Avoiding pitfalls in designing next gen trials in RCC” at #MLS #Cleveland @CParkMD @PBarataMD @GUONCGarciaJA @UHhospitals @caseccc @CleClinicMD @kidneycan @DanaFarber_GU
Tweet media one
Tweet media two
Tweet media three
Tweet media four
2
13
60
@shilpaonc
Shilpa Gupta
1 month
#ESMO2024 Amazing & clear overview of T cell engagers in Pca & future therapeutic strategies by the one & only @neerajaiims Finally a lot of excitement with IO in Pca! @mishabeltran @dmukherji @montypal @AzadOncology @PCF_Science @LenAppleman @PGrivasMDPhD @Ecastromarcos
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
20
60
@shilpaonc
Shilpa Gupta
5 months
Incredibly honored to be a part of the @ASCO #ASCO -LDP class of 2024-25 & look forward to a life altering experience w/ my classmates & mentors. Beyond grateful to @montypal @TonsterPS for this opportunity! @BrainTumorDoc @n8pennell @CleClinicMD
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
5 months
The @ASCO #ASCO_LDP reception last night was 🔥! Thank you @ASCO for investing in LDP- a completely transformative experience!
Tweet media one
2
11
53
9
7
59
@shilpaonc
Shilpa Gupta
2 years
An amazing dinner with our guest speaker @DrChoueiri @albatrosCLE with @DrOmarMian @cjweight @NimaSharifiMD #Youssef Mahfoud @CleClinicMD @CleClinic_GUMRC @CleClinicUro Great food and great discussions of science, travels and different cultures.
Tweet media one
0
4
59
@shilpaonc
Shilpa Gupta
3 years
An absolutely amazing and thought provoking TED talk by @DrSpratticus reflecting on his journey “Purpose with Pure Intent” Fantastic thoughts on finding your own purpose in life and succeeding. @caseccc @CaseUrology @CleClinicMD
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
8
58
@shilpaonc
Shilpa Gupta
8 months
Thanks @GUONCGarciaJA for the invitation to give GR @UHhospitals @caseccc Great to see friends & colleagues @JasonBrownMDPhD @PBarataM @AJangMD Look forward to building more collaborations @CleClinicMD
Tweet media one
2
9
58
@shilpaonc
Shilpa Gupta
11 months
The future of @NCIResearchCtr is in great hands with the true visionary @KimrynRathmell taking charge as the director! Best leaders rise to the top #womeninSTEM @NIHDirector @AmerCancerCEO @brian_rini @apolo_andrea @gulleyj1 @Dr_RaviMadan @neerajaiims @montypal
@kidneycan
KidneyCAN
11 months
What a win for all of us! 🤩 @KimrynRathmell , renowned #kidneycancer expert and frequent speaker at #KCRS , has been appointed by @POTUS as the new Director of @theNCI . Congratulations, Dr. Rathmell! 🌟 #KidneyCancerResearch #NCI #CancerMoonshot #AcceleratingCures @OncoAlert
Tweet media one
Tweet media two
3
15
75
2
11
58
@shilpaonc
Shilpa Gupta
3 years
Congrats @ERPlimackMD on your new role as Deputy Director of @FoxChaseCancer So greatly deserved! A huge win for @FoxChaseCancer to reach even higher heights under your leadership!
@HemOncToday
HemOnc Today
3 years
Elizabeth Plimack, MD appointed deputy director of Fox Chase Cancer Center Read more: #MedNews #oncology @ERPlimackMD @FoxChaseCancer
19
11
75
5
3
58
@shilpaonc
Shilpa Gupta
2 years
Honored to come to Jeddah for @OncologySaudi 2nd Int’l GU Cancer Conference hosted by the visionary @MMALMAN Amazed by hospitality & kindness throughout the day long travels and arrival! @GTumors @SIU_urology @neerajaiims @AndreaNecchi @FaltasLab
Tweet media one
Tweet media two
Tweet media three
6
3
56
@shilpaonc
Shilpa Gupta
1 year
@myESMO Congrats @AmandaNizamMD @CleClinicMD for the best poster award on real world biomarkers of toxicity with EV in #UNITE study. Kudos @koshkin85 on your leadership of this huge effort! @deepak_kilari @Tanjin097 @PGrivasMDPhD
Tweet media one
Tweet media two
Tweet media three
8
11
57
@shilpaonc
Shilpa Gupta
4 months
Thanks @PGrivasMDPhD for organizing the 10th annual 🇬🇷 dinner @ASCO What an amazing evening w/ friends & colleagues! And the grand finale with wishing @montypal a happy birthday 🎂 Missed @neerajaiims 🎉 Thx @LaurenMachos @GaryGreenwald8 for organizing
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
12
56
@shilpaonc
Shilpa Gupta
2 years
On my way to attend the 1st in-person #UromigosLive @Uromigos meeting in Nashville! 🤠🤠 Looking forward to facilitating social media discussions for hot topics in #BladderCancer along with @montypal #kidneycancer and @neerajaiims #ProstateCancer @brian_rini @tompowles1
Tweet media one
@Uromigos
Uromigos
2 years
Bladder Cancel Panel Livestream link: Prostate Cancer Panel Livestream link: RCC Panel Panel Livestream link:
Tweet media one
1
10
25
0
5
57
@shilpaonc
Shilpa Gupta
2 years
So proud of @CleClinicLCM MS2 Nikhil Pramod on leading our work on dissecting Dissecting immuno-genomic pathways of response & resistance to IO in mUC in a real world cohort. Poster 2278 @AACR #AACR23 @jamecancerdoc #MarcelaDiaz @CCLRI @PGrivasMDPhD @CleClinicMD @DrOmarMian
Tweet media one
2
8
55
@shilpaonc
Shilpa Gupta
6 months
Congrats @montypal & team on this novel work on CD70-targeted CAR-T-cell Tx for RCC! This sets the stage for CAR-T cells in GU tumors! @neerajaiims @MosheOrnsteinMD @PGrivasMDPhD @KCA_Journal @Uromigos @DrChoueiri @TiansterZhang @TDorffOnc
@CD_AACR
Cancer Discovery
6 months
Just published with the #AACR24 Clinical Plenary presentation: CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell #Carcinoma , by @montypal et al. @cityofhope @AACR
Tweet media one
4
40
87
0
16
55
@shilpaonc
Shilpa Gupta
2 years
Beautiful Dal Lake, Srinagar 🇮🇳
Tweet media one
Tweet media two
Tweet media three
0
0
53
@shilpaonc
Shilpa Gupta
1 year
Excited to present #AUA23 PD09-10: Avelumab maintenance for mUC: long-term outcomes from JAVELIN Bladder 100 in subgroups defined by response to 1L chemo. @PGrivasMDPhD @tompowles1 @kalasri3 @CleClinicMD @jamecancerdoc @BladderCancerUS
1
11
54
@shilpaonc
Shilpa Gupta
1 year
EV pembro outshine platinums in 1L mUC! Glad to have had this practice changing trial available to our patients @CleClinicMD @jamecancerdoc @tompowles1 @DrChoueiri @DrRosenbergMSK @apolo_andrea @PGrivasMDPhD @Uromigos @neerajaiims @montypal @drenriquegrande 👇👇
@DrChoueiri
Toni Choueiri, MD
1 year
HUGE NEWS: EV/Pembro combo tops platinum-based chemo, a SOC for 30+years, in 1L bladder cancer: a new era ….PFS/OS met!
Tweet media one
4
119
399
0
8
54
@shilpaonc
Shilpa Gupta
2 years
Seeing friends again was one of the biggest perks of attending #GU23 @ASCO @TiansterZhang @tompowles1 @ProfSyedHussain
Tweet media one
1
0
54
@shilpaonc
Shilpa Gupta
1 year
@TiansterZhang
Tian Zhang, MD, MHS
1 year
Just in: @ALLIANCE_org A031501 AMBASSADOR trial of adjuvant pembrolizumab extends disease free survival for resected #bladdercancer ! Kudos to @apolo_andrea & @NCICTEP_ClinRes NCTN teams, & all pts who participated!!
Tweet media one
1
32
91
0
13
53
@shilpaonc
Shilpa Gupta
3 months
Thx to the awesome @ASCO staff (DevonWilliams Candice Griffin) for a fantastic 1st LDP session w/team bldg exercises w/ amazing classmates @IbiayiMD @BHenickMD #ManaliBhaveMD & mentor #TiffanyTrainaMD under leadership of @montypal A lot to reflect on! @DrMarkham
Tweet media one
Tweet media two
Tweet media three
Tweet media four
4
10
52
@shilpaonc
Shilpa Gupta
6 years
Excited to present our criteria defining "platinum-ineligibility" in #bladdercancer on behalf of Platinum Ineligibility in BCa Working Group @sonpavde @MattGalsky @apolo_andrea @PGrivasMDPhD @ERPlimackMD Jonathan Rosenberg @MSKCC_OncoNotes @UMNCancer #GU19 @bcan_chisolm
3
9
51
@shilpaonc
Shilpa Gupta
3 years
Looking forward to #ASCO21 plenary session featuring VISION trial of Lu177 PSMA directed therapy #mCRPC presented by @morr316 and KEYNOTE-564 trial of adjuvant pembrolziumab in RCC presented by @DrChoueiri #Cleclincancer @jamecancerdoc @kcCURE @PCF_Science @ASCO
0
16
51
@shilpaonc
Shilpa Gupta
7 months
Thx @MosheOrnsteinMD for signing my copy of “ Cancer in Halachah”! Congrats on this tremendous achievement & providing the 1st of its kind resource for pts & caregivers on medical and Jewish law/ethics considerations in cancer screening/tx! Available on @amazon @CleClinicMD
Tweet media one
Tweet media two
Tweet media three
@MosheOrnsteinMD
Moshe Ornstein MD
8 months
Thrilled – Thanks God – to finally bring this to the finish line. “Cancer in Halachah” covers the medical and halachic (Jewish law/ethics) considerations of cancer screening and treatment. Full of practical advice and suggestions for patients.
Tweet media one
22
27
141
2
10
51
@shilpaonc
Shilpa Gupta
2 years
So happy to see @montypal and @NehaVapiwala elected to the @ASCO Nominating Committee!! Congratulations!!
@GUONCGarciaJA
JAGarciaMD
2 years
Congrats to Monti and Neha for this remarkable accomplishment! Way to go GU colleagues
Tweet media one
0
1
23
2
7
51
@shilpaonc
Shilpa Gupta
4 years
Starting 2021 with feeling #grateful after getting the #Covid19 @moderna_tx vaccine today- great way to start the new year filled with hope and a step forward to put #COVID19 behind us. @ClevelandClinic
Tweet media one
2
0
50
@shilpaonc
Shilpa Gupta
2 years
During rounds, was amazed to see beautiful towel animals made by Aletta from inpatient housekeeping for patients @CleClinicMD #Littlethings matter #KindnessMatters @jamecancerdoc
Tweet media one
Tweet media two
2
4
48
@shilpaonc
Shilpa Gupta
3 years
We are looking for a GU Oncologist interested in clinical/translational research to join our GU group @CleClinicMD @CleClinic_GUMRC Please DM if interested! @jamecancerdoc @MosheOrnsteinMD @ChrisWeeMD @TimGilliganMD @DrOmarMian @NimaSharifiMD @GeneCollector @RTendulkarMD
0
23
49
@shilpaonc
Shilpa Gupta
2 months
@nataliagandur
Dra. María Natalia Gandur Quiroga
2 months
💫🌟Phase II Trial of Intermittent Therapy in Patients with Metastatic Renal Cell Carcinoma Treated with Front-line Ipilimumab and Nivolumab 🌟💫 @MosheOrnsteinMD , @LaethGeorge , @globalsurgallie @arnabguonc , @katyn_beckermann , @AmandaNizam , @ChrisWeeMD , @TimGilliganMD ,
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
12
31
4
10
49
@shilpaonc
Shilpa Gupta
4 months
Had an evening at the @ASCO President's reception celebrating the amazing work by @lynn_schuchte @jrgralow @CliffordHudis @ASCOPres to advance ASCO's mission globally. Glad to see old & new friends & the amazing @ASCO staff @AmandaBinDC
Tweet media one
Tweet media two
Tweet media three
0
10
47
@shilpaonc
Shilpa Gupta
2 years
TMB appears to be a promising biomarker to predict OS/PFS with IO in cis-ineligible mUC as seen in our RWE and in 1st line RCTs Danube, Imvigor130 and KN361 in mUC. Need to think of designing trials to prospectively study utility of TMB @tompowles1 @DrRosenbergMSK @OncoAlert
Tweet media one
3
16
46
@shilpaonc
Shilpa Gupta
2 years
#GU23 Practice changing results from TRITON2 presented by @neerajaiims showing significant rOFS, ORar, QaoL improvement with talazoparib+enza vs placebo+enza in 1L CRPC regardless of HRR status. @Huntsman_GU
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
11
48
@shilpaonc
Shilpa Gupta
2 years
Tweet media one
@jamecancerdoc
Jame Abraham, MD, FACP
2 years
MAIN-CAV Trial Investigates Maintenance Cabozantinib plus Avelumab in Metastatic Urothelial Cancer via @CleClinicMD @shilpaonc
2
1
16
3
20
48